Safety and Efficacy of Lenvatinib Plus Nivolumab in Unresectable Hepatocellular Carcinoma: A Retrospective Study in China. (2022) - Huang, X.; Huang, Z.; Wang, C.; Yin, X.; Xu, L.; Ma, T.; Ran, Y.; Bi, X.; Che, X.